Health News page: 1 next
'Still Healing': 'Selling Sunset' Star Jason Oppenheim Talks Chrishell Stause Split
Jason Oppenheim and Chrishell Stause split amid filming on Netflix's Selling Sunset season five. And, after fans watched the breakup play out on the show, the realtor spoke out about his heartache. Watching 'Selling Sunset' Was A
Change at the top for Biogen after Alzheimer's drug flops
Lebanon Express | 2022-05-03, 14:49
MATTHEW PERRONE and TOM MURPHY Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers. CEO Michel Vounatsos
Biogen-Alzheimer's Drug
Magic Valley | 2022-05-03, 14:49
The Biogen Inc., headquarters, March 11, 2020, in Cambridge, Mass. Biogen is looking for a new CEO, less than a year after its launch of its Alzheimer’s drug Aduhelm largely fizzled. The company said Tuesday, May 3, 2022 that current ...
New study validates predictive biomarkers in diabetic kidney disease, an important step in precision medicine.
Victoria Advocate | 2022-05-03, 14:47
NaviDKD™ proactive screening technology for kidney health from Journey Biosciences confirmed in type 2 diabetes population. LEBANON, N.H., May 3, 2022 /PRNewswire/ -- Journey Biosciences, Inc. A new study recently published in the journal Diabetes Care
Liver Patients, Families, and Medical Professionals Walk to End Liver Disease
Victoria Advocate | 2022-05-03, 14:46
Liver Life Walks return in person this summer NEW YORK, May 3, 2022 /PRNewswire/ -- The American Liver Foundation (ALF) will host its annual Liver Life Walk�beginning on Monday, May 7, 2022. There will be 11 in-person walks across the country and one virtual
San Diego's Cardea Bio nets Gates Foundation grant to uncover COVID, malaria and other diseases ...
San Diego Union-Tribune | 2022-05-03, 14:36
The company's bio-sensing platform melds tiny bits of biological material with semiconductors for real time monitoring ...
Global Genes and the Orphan Disease Center of the University of Pennsylvania Host 7th Annual ...
The Galveston Daily News | 2022-05-03, 14:24
ALISO VIEJO, Calif.--(BUSINESS WIRE)--May 3, 2022-- Global Genes, a leading rare disease patient advocacy organization, today announced its 7th annual RARE Drug Development Symposium (RDDS), in partnership with the Orphan Disease Center at the University of
Cardea Bio receives funding to develop electronic nose to rapidly diagnose infectious diseases via breath
SAN DIEGO, May 3, 2022 /PRNewswire/ -- Today, Cardea Bio, Inc. - the world's only mass producer of biocompatible semiconductors - announced that it has been awarded a $1.1 million USD grant by the Bill & Melinda Gates Foundation to develop a BPU™
This many hours of sleep can help avoid Alzheimer's and anxiety
Seven hours of sleep per night is the sweet spot for middle-aged and older adults, according to a study that found any more or less was tied to cognitive impairment and poorer mental health. Story continues below This advertisement has not loaded yet, but your
IG Wealth Management Walk for Alzheimer's returns as Canada's largest fundraiser for dementia Français
Alzheimer Society Logo (CNW Group/Alzheimer Society of Canada) IG Wealth Management Logo (CNW Group/Alzheimer Society of Canada) TORONTO, /CNW/ - On the weekend of , Canadians will once again lace-up for the IG Wealth Management Walk for Alzheimer's ("the
First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India ...
Salt Lake City, United States: Foldax®, Inc. today announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIA™ biopolymer surgical aortic heart
Mystery liver disease kills three children in Indonesia
Three children in Indonesia have died from a mysterious liver disease, the country's health ministry said, raising to at least four the global death toll of a fatal ailment puzzling doctors from the Europe and the US to Asia. This severe strain of acute
Mining City History: Newbro famous for Herpicide 'dandruff cure'
Montana Standard | 2022-05-03, 14:00
RICHARD I. GIBSON for The Montana Standard DuPont Morse Newbro was born in Lansing, Michigan, in 1865. By the time he was 20 years old, he was working there as an apprentice pharmacist and druggist, when he pulled up stakes and moved to Helena, Montana. After
NUI Galway leads new research project on neurological diseases (National University of Ireland, Galway)
) Professor Bob Lahue, of the Centre for Chromosome Biology and the Galway Neuroscience Centre at NUI Galway. Credit: NUI Galway. Researchers at three universities in Ireland, Scotland and Wales are joining forces to develop new tools for identifying drugs to
RG6501 (OpRegen®) Phase 1/2a Clinical Results Support the Potential for OpRegen to Slow, Stop or Reverse Disease Progression in Geographic Atrophy Secondary to Age-Related Macular Degeneration (Lineage Cell Therapeutics Inc)
) PDF Version 12-Month Primary Endpoint Data Suggest OpRegen is Well Tolerated with an Acceptable Safety Profile Preliminary Evidence of Visual Function and Outer Retinal Structure Improvements Observed in Cohort 4 Patients with GA and Impaired Vision Data
Mystery liver disease kills 3 more children after “significant increase” in cases
▶ Watch Video: CDC issues alert over hepatitis outbreak in kids Three children in Indonesia have died from a mysterious liver disease, the country’s health ministry said, raising to at least four the global death toll of a fatal ailment puzzling doctors
Biogen Searches for New CEO in Wake of Struggles With Alzheimer’s Drug Launch
Shares of Biogen rose in premarket trading Tuesday after
Genetic links discovered between Coronavirus and other diseases
A team of US researchers has uncovered genetic links between Covid-19 severity and certain medical conditions that are known risk factors for severity of the infectious disease. Some people with Covid experience the disease more severely than others, and
Dental Disease Prevention and Treatment like Tooth Decay Cavities, Dental Caries, and Gum Diseases
Go to the source via the article link to view the video. ...
Behind The Fear: The Hidden Story of HIV (full doc link in description)
Go to the source via the article link to view the video. ...
Global Systemic Scleroderma Treatment Market to 2028 - by Drug Class, Disease Type, Route of ...
The Galveston Daily News | 2022-05-03, 13:29
DUBLIN--(BUSINESS WIRE)--May 3, 2022-- The "Systemic Scleroderma Treatment Market, by Drug Class, by Disease Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been
Penny Lebyane debunks myths around traditional healing in ‘Sangoma, Khanyisa!’
Radio and TV personality Penny Lebyane is back on the small screen as the host of Sangoma, Khanyisa! on Honey. The show sees renowned traditional healer Mkhulu Rametsi, real name Tokologo Thwane, help deliver life-changing messages as he takes viewers on a
This Maryland biotech’s ADHD drug just earned FDA approval — this time, for adults
The drug is already available to children and adolescents. ...
BioXcel Therapeutics Announces First Patient Dosed in TRANQUILITY II Phase 3 Trial for Acute Treatment of Agitation in Patients with Alzheimer’s Disease (BioXcel Therapeutics Inc)
) BioXcel Therapeutics Announces First Patient Dosed in TRANQUILITY II Phase 3 Trial for Acute Treatment of Agitation in Patients with Alzheimer's Disease May 3, 2022 Top-line data for TRANQUILITY II anticipated in Q4 2022/early Q1 2023 Phase 3 TRANQUILITY III
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of PH-10 Immuno-Dermatology Agent for Treatment of Inflammatory Dermatoses and Epithelial Diseases (Provectus Biopharmaceuticals Inc)
) KNOXVILLE, TN, May 3, 2022 (GLOBE NEWSWIRE) - Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed US patent (USP) application 16/204,832, "," covering the use of topical PH-10, a
Bridging Pharmacokinetics Study Part 1 Recruitment Completed for XRx-008 Program for Autosomal Dominant Polycystic Kidney Disease - Form 6-K (XORTX Therapeutics Inc)
) Bridging Pharmacokinetics Study Part 1 Recruitment Completed for XRx-008 Program for Autosomal Dominant Polycystic Kidney Disease CALGARY, Alberta, May 03, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company")
7% of German population has no Covid immunity, disease body says
Marietta Daily Journal | 2022-05-03, 12:53
Biogen'a Q1 profit and revenue lag estimates, weighed down by Alzheimer's drug
Shares of Biogen Inc. BIIB, -0.06% fell 2.3% in premarket trading on Tuesday after the company missed Wall Street's expectations for revenue and earnings for the first quarter of 2022. Biogen had net income of
Body Numbness and Diarrhea got cured following POEM Protocol
Go to the source via the article link to view the video. ...
